Your browser doesn't support javascript.
loading
Role of the Fc Region in the Vitreous Half-Life of Anti-VEGF Drugs.
Joo, Kwangsic; Park, Sang Jun; Choi, Yewon; Lee, Jung Eun; Na, Young Mi; Hong, Hye Kyoung; Park, Kyu Hyung; Kim, Ho Min; Chung, Jae-Yong; Woo, Se Joon.
Afiliação
  • Joo K; Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Park SJ; Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Choi Y; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Bundang Hospital, Seongnam, Republic of Korea.
  • Lee JE; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
  • Na YM; New Drug Development Center, Osong Medical Innovation Foundation, Cheongju, Republic of Korea.
  • Hong HK; Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Park KH; Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Kim HM; Department of Ophthalmology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
  • Chung JY; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.
  • Woo SJ; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Bundang Hospital, Seongnam, Republic of Korea.
Invest Ophthalmol Vis Sci ; 58(10): 4261-4267, 2017 08 01.
Article em En | MEDLINE | ID: mdl-28850637
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Corpo Vítreo / Proteínas Recombinantes de Fusão / Fragmentos Fc das Imunoglobulinas / Inibidores da Angiogênese / Fator A de Crescimento do Endotélio Vascular / Bevacizumab Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Corpo Vítreo / Proteínas Recombinantes de Fusão / Fragmentos Fc das Imunoglobulinas / Inibidores da Angiogênese / Fator A de Crescimento do Endotélio Vascular / Bevacizumab Idioma: En Ano de publicação: 2017 Tipo de documento: Article